Halogenated aromatic amino acid 3,5-dibromo-D: -tyrosine produces beneficial effects in experimental stroke and seizures.
Halogenated aromatic amino acid 3,5-dibromo-D: -tyrosine produces beneficial effects in experimental stroke and seizures.
复制标题
DOI：
10.1007/s00726-010-0739-4
复制
发表时间：
2011-04
期刊：
影响因子：
3.5
通讯作者：
Martynyuk AE
中科院分区：
文献类型：
--
作者：
Cao W;Glushakov A;Shah HP;Mecca AP;Sumners C;Shi P;Seubert CN;Martynyuk AE
The effects of the halogenated aromatic amino acid 3,5-dibromo-d-tyrosine (3,5-DBr-d-Tyr) were studied in rat models of stroke and epileptic seizures caused by middle cerebral artery occlusion (MCAo) through respective intracerebral injection of endothelin-1 (ET-1) and intraperitoneal (i.p.) injection of pentylenetetrazole (PTZ). 3,5-DBr-d-Tyr was administered as three bolus injections (30 or 90 mg/kg, i.p.) starting at 30, 90, and 180 min after ET-1 administration or as a single bolus (30 mg/kg, i.p.) 15 min prior to PTZ administration. Neurological deficits and infarct volume were estimated 3 days after ET-1 administration and seizure score was assessed during the first 20 min after PTZ administration. The safety of 3,5-DBr-d-Tyr was evaluated in control animals using telemetry to measure cardiovascular parameters and immunostaining to assess the level of activated caspase-3. 3,5-DBr-d-Tyr significantly improved neurological function and reduced infarct volume in the brain even when the treatment was initiated 3 h after the onset of MCAo. 3,5-DBr-d-Tyr significantly depressed PTZ-induced seizures. 3,5-DBr-d-Tyr did not cause significant changes in arterial blood pressure, heart rate and spontaneous locomotor activity, nor did it increase the number of activated caspase-3 positive cells in the brain. We conclude that 3,5-DBr-d-Tyr, by alleviating the deleterious effects of MCAo and PTZ in rats with no obvious intrinsic effects on cardiovascular parameters and neurodegeneration, exhibits promising potential as a novel therapeutic direction for stroke and seizures.
登录
查看更多内容
影响因子：
8.3
作者：
GARCIA, JH;WAGNER, S;HU, XJ
通讯作者：
HU, XJ
影响因子：
7.3
作者：
Cao, W.;Shah, H. P.;Martynyuk, A. E.
通讯作者：
Martynyuk, A. E.
影响因子：
3.3
作者：
Exner, M;Hermann, M;Gmeiner, BMK
通讯作者：
Gmeiner, BMK
影响因子：
3.9
作者：
Hardingham GE
通讯作者：
Hardingham GE
影响因子：
3.6
作者：
Yarotskyy, V;Glushakov, AV;Martynyuk, AE
通讯作者：
Martynyuk, AE